Recruiting now
-
Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Phase 2 · 34 people · 1 site in China · Recruiting now
-
IDOV-Immune for Advanced Solid Tumors
Phase 1 · 78 people · 5 sites in 2 countries · Recruiting now
-
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 162 people · 29 sites in 10 countries · Recruiting now
-
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (“Chip-CRC Trial”)
Phase 2 · 28 people · 1 site in United States · Recruiting now
-
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
Early phase 1 · 120 people · 1 site in United States · Recruiting now
-
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Phase 2 · 49 people · 1 site in China · Recruiting now